Author
Listed:
- Johanna Diener
(University of Zürich, Institute of Anatomy)
- Arianna Baggiolini
(University of Zürich, Institute of Anatomy
Memorial Sloan Kettering Cancer Center)
- Mattias Pernebrink
(Linköping University
Linköping University)
- Damian Dalcher
(University of Zürich, Department of Molecular Mechanisms of Disease)
- Luigi Lerra
(University of Zürich, Department of Molecular Mechanisms of Disease)
- Phil F. Cheng
(University Hospital of Zürich, Department of Dermatology)
- Sandra Varum
(University of Zürich, Institute of Anatomy)
- Jessica Häusel
(University of Zürich, Institute of Anatomy)
- Salome Stierli
(University of Zürich, Institute of Anatomy)
- Mathias Treier
(Max-Delbrück-Center for Molecular Medicine
Charité-Universitätsmedizin Berlin)
- Lorenz Studer
(Memorial Sloan Kettering Cancer Center)
- Konrad Basler
(University of Zürich, Institute of Molecular Life Sciences)
- Mitchell P. Levesque
(University Hospital of Zürich, Department of Dermatology)
- Reinhard Dummer
(University Hospital of Zürich, Department of Dermatology)
- Raffaella Santoro
(University of Zürich, Department of Molecular Mechanisms of Disease)
- Claudio Cantù
(Linköping University
Linköping University
University of Zürich, Institute of Molecular Life Sciences)
- Lukas Sommer
(University of Zürich, Institute of Anatomy)
Abstract
Melanoma cells rely on developmental programs during tumor initiation and progression. Here we show that the embryonic stem cell (ESC) factor Sall4 is re-expressed in the Tyr::NrasQ61K; Cdkn2a−/− melanoma model and that its expression is necessary for primary melanoma formation. Surprisingly, while Sall4 loss prevents tumor formation, it promotes micrometastases to distant organs in this melanoma-prone mouse model. Transcriptional profiling and in vitro assays using human melanoma cells demonstrate that SALL4 loss induces a phenotype switch and the acquisition of an invasive phenotype. We show that SALL4 negatively regulates invasiveness through interaction with the histone deacetylase (HDAC) 2 and direct co-binding to a set of invasiveness genes. Consequently, SALL4 knock down, as well as HDAC inhibition, promote the expression of an invasive signature, while inhibition of histone acetylation partially reverts the invasiveness program induced by SALL4 loss. Thus, SALL4 appears to regulate phenotype switching in melanoma through an HDAC2-mediated mechanism.
Suggested Citation
Johanna Diener & Arianna Baggiolini & Mattias Pernebrink & Damian Dalcher & Luigi Lerra & Phil F. Cheng & Sandra Varum & Jessica Häusel & Salome Stierli & Mathias Treier & Lorenz Studer & Konrad Basle, 2021.
"Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4,"
Nature Communications, Nature, vol. 12(1), pages 1-18, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25326-8
DOI: 10.1038/s41467-021-25326-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25326-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.